These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9138108)

  • 1. Effect of glucan on murine lupus evolution and on host resistance to Klebsiella pneumoniae.
    Harima HA; Mendes NF; Mamizuka EM; Mariano M
    J Clin Lab Anal; 1997; 11(3):175-8. PubMed ID: 9138108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Protective activity of a cell-free Klebsiella vaccine in relation to different Klebsiella pneumoniae serovars].
    Kurbatova EA; Egorova NB; Kiseleva BS
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Aug; (8):80-3. PubMed ID: 6385585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous IL-10 leads to impaired bacterial clearance and reduced survival in a murine model of chronic peritonitis.
    Lenz AM; Franklin GA; Fairweather M; McClintock ML; Jala VR; Peyton JC; Gardner SA; Cheadle WG
    Cytokine; 2007 Dec; 40(3):207-15. PubMed ID: 18053738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNAse treatment does not improve the survival of lupus prone (NZB x NZW)F1 mice.
    Verthelyi D; Dybdal N; Elias KA; Klinman DM
    Lupus; 1998; 7(4):223-30. PubMed ID: 9643311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The lupus-susceptibility locus, Sle3, mediates enhanced resistance to bacterial infections.
    Mehrad B; Park SJ; Akangire G; Standiford TJ; Wu T; Zhu J; Mohan C
    J Immunol; 2006 Mar; 176(5):3233-9. PubMed ID: 16493084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with the outer membrane proteins OmpK17 and OmpK36 elicits protection against Klebsiella pneumoniae in the murine infection model.
    Hussein KE; Bahey-El-Din M; Sheweita SA
    Microb Pathog; 2018 Jun; 119():12-18. PubMed ID: 29626658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial infection modulated by glucan: a search for the host defense potentiation mechanisms.
    Franĕk J; Malina J; Krátká H
    Folia Microbiol (Praha); 1992; 37(2):146-52. PubMed ID: 1505872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus.
    Bahjat FR; Pine PR; Reitsma A; Cassafer G; Baluom M; Grillo S; Chang B; Zhao FF; Payan DG; Grossbard EB; Daikh DI
    Arthritis Rheum; 2008 May; 58(5):1433-44. PubMed ID: 18438845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan.
    Fagone P; Mangano K; Mammana S; Quattrocchi C; Magro G; Coco M; Imene S; Di Marco R; Nicoletti F
    Lupus; 2014 Apr; 23(4):407-11. PubMed ID: 24493283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW; Elbourne KB; Lagoo A; Lal S
    J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel susceptibility locus on chromosome 2 in the (New Zealand Black x New Zealand White)F1 hybrid mouse model of systemic lupus erythematosus.
    Rahman ZS; Tin SK; Buenaventura PN; Ho CH; Yap EP; Yong RY; Koh DR
    J Immunol; 2002 Mar; 168(6):3042-9. PubMed ID: 11884477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB x NZW)F1 mice.
    Reininger L; Winkler TH; Kalberer CP; Jourdan M; Melchers F; Rolink AG
    J Exp Med; 1996 Sep; 184(3):853-61. PubMed ID: 9064345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of orally administered, Klebsiella-containing bacterial lysates in mice.
    Kuenen JD; van Dijke EE; Hol C; Bootsma HJ; Verhoef J; van Dijk H
    FEMS Immunol Med Microbiol; 1994 Jan; 8(1):69-75. PubMed ID: 8156053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early hyperbaric oxygen therapy attenuates disease severity in lupus-prone autoimmune (NZB x NZW) F1 mice.
    Chen SY; Chen YC; Wang JK; Hsu HP; Ho PS; Chen YC; Sytwu HK
    Clin Immunol; 2003 Aug; 108(2):103-10. PubMed ID: 12921756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapeutic modification of Escherichia coli--induced experimental peritonitis and bacteremia by glucan.
    Williams DL; Browder IW; Di Luzio NR
    Surgery; 1983 Mar; 93(3):448-54. PubMed ID: 6338616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide-induced resistance in mice against ascending urinary tract infection with Klebsiella pneumoniae.
    Chathley UC; Sharma S; Chhibber S
    Folia Microbiol (Praha); 1996; 41(4):373-6. PubMed ID: 9131794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired long-term immune protection following pneumococcal 13-valent/23-valent polysaccharide vaccine in systemic lupus erythematosus (SLE).
    Sacre K; Goulenok T; Bahuaud M; Francois C; Van der Haegen MC; Alexandra JF; Aucouturier P; Hurtado-Nedelec M; Moins-Teisserenc H; Batteux F; Papo T
    Ann Rheum Dis; 2018 Oct; 77(10):1540-1542. PubMed ID: 29444908
    [No Abstract]   [Full Text] [Related]  

  • 19. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae.
    Happel KI; Dubin PJ; Zheng M; Ghilardi N; Lockhart C; Quinton LJ; Odden AR; Shellito JE; Bagby GJ; Nelson S; Kolls JK
    J Exp Med; 2005 Sep; 202(6):761-9. PubMed ID: 16157683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strong acceleration of murine lupus by injection of the SmD1(83-119) peptide.
    Riemekasten G; Kawald A; Weiss C; Meine A; Marell J; Klein R; Hocher B; Meisel C; Hausdorf G; Manz R; Kamradt T; Burmester GR; Hiepe F
    Arthritis Rheum; 2001 Oct; 44(10):2435-45. PubMed ID: 11665986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.